Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125710331 | 12571033 | 1 | I | 20160516 | 20160712 | 20160719 | 20160719 | EXP | FR-UCBSA-2016026358 | UCB | 63.00 | YR | M | Y | 0.00000 | 20160719 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125710331 | 12571033 | 1 | PS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Subcutaneous | 400 MG, UNK | Y | U | 125160 | 400 | MG | SOLUTION FOR INJECTION | |||||
| 125710331 | 12571033 | 2 | C | EXFORGE | AMLODIPINE BESYLATEVALSARTAN | 1 | UNK (5MG/80MG) | U | 0 | FILM-COATED TABLET | |||||||||
| 125710331 | 12571033 | 3 | C | Ezetrol | EZETIMIBE | 1 | UNK (10MG) | U | 0 | TABLET | |||||||||
| 125710331 | 12571033 | 4 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | UNK | U | 0 | ||||||||||
| 125710331 | 12571033 | 5 | C | DOLIPRANE | ACETAMINOPHEN | 1 | UNK | U | 0 | ||||||||||
| 125710331 | 12571033 | 6 | C | Rifinah | ISONIAZIDRIFAMPIN | 1 | UNK | U | 0 | ||||||||||
| 125710331 | 12571033 | 7 | C | CEFOTAXIME | CEFOTAXIME SODIUM | 1 | UNK | U | 0 | ||||||||||
| 125710331 | 12571033 | 8 | C | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | UNK | U | 0 | ||||||||||
| 125710331 | 12571033 | 9 | C | FLUCONAZOLE. | FLUCONAZOLE | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125710331 | 12571033 | 1 | Ankylosing spondylitis |
| 125710331 | 12571033 | 2 | Product used for unknown indication |
| 125710331 | 12571033 | 3 | Product used for unknown indication |
| 125710331 | 12571033 | 4 | Product used for unknown indication |
| 125710331 | 12571033 | 5 | Product used for unknown indication |
| 125710331 | 12571033 | 6 | Tuberculosis |
| 125710331 | 12571033 | 7 | Infection |
| 125710331 | 12571033 | 8 | Infection |
| 125710331 | 12571033 | 9 | Infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125710331 | 12571033 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125710331 | 12571033 | General physical health deterioration | |
| 125710331 | 12571033 | Pneumonia | |
| 125710331 | 12571033 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125710331 | 12571033 | 1 | 20160427 | 2016 | 0 | |
| 125710331 | 12571033 | 2 | 201606 | 0 | ||
| 125710331 | 12571033 | 6 | 201603 | 20160608 | 0 | |
| 125710331 | 12571033 | 7 | 2016 | 0 | ||
| 125710331 | 12571033 | 8 | 2016 | 0 | ||
| 125710331 | 12571033 | 9 | 2016 | 0 |